Cannabidiol Treatment Improves Glucose Metabolism and Memory in Streptozotocin-Induced Alzheimer’s Disease Rat Model: A Proof-of-Concept Study

An early and persistent sign of Alzheimer’s disease (AD) is glucose hypometabolism, which can be evaluated by positron emission tomography (PET) with (18)F-2-fluoro-2-deoxy-D-glucose ([(18)F]FDG). Cannabidiol has demonstrated neuroprotective and anti-inflammatory properties but has not been evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: de Paula Faria, Daniele, Estessi de Souza, Larissa, Duran, Fabio Luis de Souza, Buchpiguel, Carlos Alberto, Britto, Luiz Roberto, Crippa, José Alexandre de Souza, Filho, Geraldo Busatto, Real, Caroline Cristiano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835532/
https://www.ncbi.nlm.nih.gov/pubmed/35163003
http://dx.doi.org/10.3390/ijms23031076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835532/
https://www.ncbi.nlm.nih.gov/pubmed/35163003
http://dx.doi.org/10.3390/ijms23031076

Ejemplares similares